Drugs · acquisition-cost intelligence
12 Hour Nasal Decongestant Extra Moisturizing
0.05% Oxymetazoline· ingredient oxymetazolineOther dermatologicals· OXYMETAZOLINE HYDROCHLORIDE .0005095 g/mL; OXYMETAZOLINE HYDROCHLORIDE .0005 g/g; OXYMETAZOLINE HYDROCHLORIDE .0005 g/mL; OXYMETAZOLINE HYDROCHLORIDE .05 g/100mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.07646
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other oxymetazoline products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Rhofade | $23.46 | +$23.39 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.